Elevated serum anti-mullerian hormone in adolescent and young adult Chinese patients with polycystic ovary syndrome

Wiener Klinische Wochenschrift

Volumn 122, Issue 17-18, 2010, Pages 519-524

  Li, Lin ^a   Chen, Xiaoli ^a   Mo, Yaqin ^a   Chen, Yaxiao ^a   Wenig, Meiying ^a   Yang, Dongzi ^a  

^a SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Adolescence; Anti mullerian hormone (AMH); Chinese; Diagnostic value; Polycistic ovary syndrome (PCOS)

Indexed keywords

MUELLERIAN INHIBITING FACTOR;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; CHINESE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HORMONE BLOOD LEVEL; HUMAN; ORGAN SIZE; OVARY POLYCYSTIC DISEASE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; ANTI-MULLERIAN HORMONE; BIOLOGICAL MARKERS; CHINA; FEMALE; HUMANS; POLYCYSTIC OVARY SYNDROME; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 77957262508     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-010-1426-x     Document Type: Article

References (27)

1. Zhu YG, Su YH, Zhang YW (2004) Polycystic ovary syndrome, In: Cao ZY (ed) Chinese Obstetrics and Gynecology, 2nd edn. Republic Health Publishing Company, Beijing, pp 2448-1
2. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group 2004 Revised 2003 on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum Reprod 19 41 47 10.1093/humrep/deh098 (Pubitemid 38072004)
3. Balen AH, Dunger D (2004) The polycystic ovary syndrome and adolescent women. In: Balen AH, Creighton SM, Davies MC, Macdougall J, Stanhope R (eds) Paediatric and adolescent gynaecology, 1st edn. Cambridge University Press, Cambridge, pp 342-53
4. DJ Salmi HC Zisser L Jovanovic 2004 Screening for and treatment of polycystic ovary syndrome in teenagers Exp Biol Med (Maywood) 229 369 377 1:CAS:528:DC%2BD2cXktlOrtb8%3D (Pubitemid 38542345)
5. RL Cate RJ Mattaliano C Hession R Tizard NM Farber A Cheung, et al. 1986 Isolation of the bovine and human genes for Mullerian inhibiting substance and expression of the human gene in animal cells Cell 45 685 698 1:CAS:528:DyaL28Xkslemuro%3D 10.1016/0092-8674(86)90783-X 3754790 (Pubitemid 16063132)
6. JL Juengel NL Hudson L Whiting KP Menatty 2005 The role of proteins of the transforming growth factor-beta superfamily in the intraovarian regulation of follicle development Hum Reprod Update 11 143 160 1:CAS:528: DC%2BD2MXitV2jtrg%3D 15705960
7. A Munsterberg R Lovell-Gadge 1991 Expression of the mouse anti-mullerian hormone gene suggests a role in both male and female sexual differentiation Development 113 613 624 1:CAS:528:DyaK3sXhs1Cisw%3D%3D 1782869
8. JA Visser FH De Jong JS Laven APN Themmen 2006 Anti-mullerian hormone: a new marker for ovary function Reproduction 13 1 9 10.1530/rep.1.00529 (Pubitemid 43230697)
9. A de Vet JS Laven FH de Jong AP Themmen BC Fauser 2002 Antimullerian hormone serum levels: a putative marker for ovarian aging Fertil Steril 77 357 362 10.1016/S0015-0282(01)02993-4 11821097 (Pubitemid 34083560)
10. WM Baarends JT Uilenbroek P Kramer JW Hoogerbtugge EC van Leeuwen AP Themmen, et al. 1995 Anti-mullerian hormone and anti-mullerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle and gonadotropin-induced follicle growth Endocrinology 136 4951 4962 1:CAS:528:DyaK2MXovFOltrs%3D 10.1210/en.136.11.4951 7588229
11. J Bezard B Vigier D Tran P Mauleon N Josso 1987 Immunocytochemical study of anti-Mullerian hormone in sheep ovarian follicles during getal and post-natal development J Reprod Fertil 80 509 516 1:CAS:528:DyaL2sXkvFShtbw%3D 10.1530/jrf.0.0800509 3309279
12. C Weenen JS Laven AR von Bergh M Cranfield NP Groome JA Visser, et al. 2004 Anti-mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment Mol Hum Reprod 10 77 83 1:CAS:528:DC%2BD2cXms1amtw%3D%3D 10.1093/molehr/gah015 14742691 (Pubitemid 38196508)
13. AL Durlinger JA Visser AP Themmen 2002 Regulation of ovarian function: the role of anti-mullerian hormone Reproduction 124 601 609 1:CAS:528: DC%2BD3sXht1Kltg%3D%3D 10.1530/rep.0.1240601 12416998 (Pubitemid 35402334)
14. FJ Broekmans JA Visser JS Laven SL Broer AP Themmen BC Fauser 2008 Anti-mullerian hormone and ovarian dysfunction Trends Endoicrinol Metab 19 340 347 1:CAS:528:DC%2BD1cXht1Klt77M 10.1016/j.tem.2008.08.002
15. JG Wang GS Nakhuda MM Guarnaccia MV Sauer RA Lobo 2007 Mullerian inhibiting substance and disrupted folliculogenesis in polycystic ovary syndrome Am J Obstet Gynecol 196 77.e1 77.e5 10.1016/j.ajog.2006.07.046 (Pubitemid 46107371)
16. JS Laven AG Mulders JA Visser AP Themmen FH de Jong BC Fauser 2004 Anti-mullerian hormone serum concentration in normoovulatory and anovulatory women of reproductive age J Clin Endocrinol Metab 89 318 323 1:CAS:528:DC%2BD2cXmvFCitw%3D%3D 10.1210/jc.2003-030932 14715867 (Pubitemid 38183899)
17. P Pigny E Merlen Y Robert C Cortet-rudelli C Decanter S Jonard, et al. 2003 Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest J Clin Endocrinol Metab 88 5957 5962 1:CAS:528: DC%2BD3sXhtVSgsrvL 10.1210/jc.2003-030727 14671196 (Pubitemid 38033078)
18. P Pigny S Jonard Y Robert D Dewaily 2005 Serum anti-mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome J Clin Endocrinol Metab 91 941 945 10.1210/jc.2005-2076 16368745 (Pubitemid 43357762)
19. L Li DZ Yang XL Chen YX Chen SY Feng LA Wang 2007 Clinical and metabolic features of polycystic ovary syndrome Int J Gynecol Obstet 97 129 134 1:CAS:528:DC%2BD2sXksVOqur0%3D 10.1016/j.ijgo.2007.01.005 (Pubitemid 46589453)
20. XL Chen DZ Yang L Li SY Feng LA Wang 2006 Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome Hum Reprod 21 2027 2032 1:CAS:528:DC%2BD28Xotl2lsrs%3D 10.1093/humrep/del142 16684838 (Pubitemid 44288077)
21. YX Chen L Li XL Chen QX Zhang WJ Wang Y Li DZ Yang 2008 Ovarian volume and follicle number in the diagnosis of polycystic ovary syndrome in Chinese women Ultrasound Obst Gyn 32 700 703 1:STN:280:DC%2BD1cnjt1ensw%3D%3D 10.1002/uog.5393
22. Y Shi M Guo J Yan W Sun X Zhang L Geng, et al. 2007 Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome Neuro Endocrinol Lett 28 807 810 1:CAS:528:DC%2BD1cXht1eju7k%3D 18063948
23. JL Zhao ZJ Chen YH Shi L Geng ZW Ma Y Li, et al. 2007 Investigation of body hair assessment of Chinese women in Shangdong region and its preliminary application in polycystic ovary syndrome patients Zhonghua fu chan ke za zhi 42 590 594 17983512 [Chinese]
24. Inoue S, Zimmet P, Caterson I, Chen CM, Ikeda Y, AK Khalid DD, et al (2000) The Asia-Pacific perspective: redefining obesity and its treatment. The 1st edn. Health Communications Australia Pty limited on behalf of the Steering Committee, pp 15-21
25. A Al-Qahtani S Muttukrishna M Appasamy J Johns M Cranfield JA Visser, et al. 2005 Development of a sensitive enzyme immunoassay for anit-mullerian hormone and the evaluation of potential clinical applications in males and females Clin Endocrinol 63 267 273 1:CAS:528:DC%2BD2MXhtVyisb%2FJ 10.1111/j.1365-2265.2005.02336.x (Pubitemid 41233443)
26. XL Chen DZ Yang YQ Mo L Li YX Chen YH Huang 2008 Prevalence of polycystic ovary syndrome in unselected women from southern China Eur J Obstet Gyn R B 139 59 64 10.1016/j.ejogrb.2007.12.018
27. N Massin G Meduri A Bachelot M Misrahi F Kuttenn P Touraine 2008 Evaluation of different markers of the ovarian reserve in patients presenting with premature ovarian failure Mol Cell Endocrinol 282 95 100 1:CAS:528:DC%2BD1cXitVegtLg%3D 10.1016/j.mce.2007.11.017 18191888